[go: up one dir, main page]

EA200601566A1 - Кристаллические формы фармацевтического соединения - Google Patents

Кристаллические формы фармацевтического соединения

Info

Publication number
EA200601566A1
EA200601566A1 EA200601566A EA200601566A EA200601566A1 EA 200601566 A1 EA200601566 A1 EA 200601566A1 EA 200601566 A EA200601566 A EA 200601566A EA 200601566 A EA200601566 A EA 200601566A EA 200601566 A1 EA200601566 A1 EA 200601566A1
Authority
EA
Eurasian Patent Office
Prior art keywords
crystal forms
pharmaceutical compounds
methyl
benzodiazocine
diindolo
Prior art date
Application number
EA200601566A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Харолд Рок
Хейди Лопес Де Диего
Ким Лассе Кристенсен
Оле Нильсен
Андерс Буур
Марк Хауэллз
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2005/000127 external-priority patent/WO2005082920A1/en
Publication of EA200601566A1 publication Critical patent/EA200601566A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA200601566A 2004-02-27 2005-02-24 Кристаллические формы фармацевтического соединения EA200601566A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400326 2004-02-27
PCT/DK2005/000127 WO2005082920A1 (en) 2004-02-27 2005-02-24 Crystalline forms of a pharmaceutical compound

Publications (1)

Publication Number Publication Date
EA200601566A1 true EA200601566A1 (ru) 2006-12-29

Family

ID=36607170

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601566A EA200601566A1 (ru) 2004-02-27 2005-02-24 Кристаллические формы фармацевтического соединения

Country Status (9)

Country Link
KR (1) KR20070012644A (es)
CN (1) CN100591685C (es)
AR (1) AR047821A1 (es)
CA (1) CA2762878C (es)
EA (1) EA200601566A1 (es)
ES (1) ES2397342T3 (es)
TW (1) TW200530254A (es)
UA (1) UA90259C2 (es)
ZA (1) ZA200606556B (es)

Also Published As

Publication number Publication date
KR20070012644A (ko) 2007-01-26
CN100591685C (zh) 2010-02-24
ES2397342T3 (es) 2013-03-06
CA2762878A1 (en) 2005-09-09
HK1102087A1 (zh) 2007-11-02
UA90259C2 (en) 2010-04-26
CN1922196A (zh) 2007-02-28
AR047821A1 (es) 2006-02-22
CA2762878C (en) 2014-08-19
TW200530254A (en) 2005-09-16
ZA200606556B (en) 2008-02-27

Similar Documents

Publication Publication Date Title
EE05222B1 (et) Triasolo(4,5-d)primidiinihendi kristalne ja amorfne vorm, meetod selle valmistamiseks ning kasutamine
EP1648853A4 (en) PHENETHYLARYLATER-BASED COMPOSITIONS AS A MEANS FOR THE SOLUBILIZATION OF ORGANIC ACTIVE SUBSTANCES
ZA200606220B (en) Galenic formulations of organic compounds
NZ600161A (en) Novel tricyclic compounds
PL378812A1 (pl) Zastosowania przeciwciał przeciw receptorowi insulinopodobnego czynnika wzrostowego I
IL183587A0 (en) Methods of using [3.2.0] heterocyclic compounds and analogs thereof
HUP0201787A2 (en) Amide derivatives substituted by heterocyclic group useful as growth hormone secretagogues, pharmaceutical compositions containing them
WO2005062897A3 (en) Polymorphs of ezetimibe and processes for the preparation thereof
EP1799208A4 (en) AROMATIC HETEROCYCLIC COMPOUNDS AS SECRETAGOGUES OF GROWTH HORMONE
AU2006224295A8 (en) N- (N-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
SG153039A1 (en) Crystalline polymorphic forms of monosodium n-[8- (2hydroxybenzoyl)amino]caprylate
EA200800992A1 (ru) 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения
SI1685125T1 (sl) Derivati pirola, primerni za zdravljenje proliferativnih bolezni
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
WO2007083188A3 (en) Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative
AU2003239508A1 (en) Indole compounds useful as impdh inhibitors
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
AU2003294747A1 (en) Stabilised compositions containing polyfunctional aziridine compounds as hardening constituents
EA200601566A1 (ru) Кристаллические формы фармацевтического соединения
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
AU2003233578A1 (en) Device for securing to wall of internal lumen
DK1280527T3 (da) Anvendelse af substituerede acryloyldistamycinderivater til behandling af tumorer associeret med höje niveauer af glutathion
TW200942546A (en) A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one
WO2006053625A8 (en) Crystalline form of cefdinir ammonium salt as an intermediate for the preparation of pure cefdinir
AU2003223107A1 (en) Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents